Suppr超能文献

相似文献

1
Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.
J Cell Mol Med. 2018 Jan;22(1):123-130. doi: 10.1111/jcmm.13300. Epub 2017 Aug 10.
2
A review of the current understanding and clinical utility of miRNAs in esophageal cancer.
Semin Cancer Biol. 2013 Dec;23(6 Pt B):512-21. doi: 10.1016/j.semcancer.2013.08.005. Epub 2013 Sep 3.
3
Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma.
Carcinogenesis. 2015 May;36(5):521-7. doi: 10.1093/carcin/bgv023. Epub 2015 Mar 16.
4
MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
World J Gastroenterol. 2017 Aug 14;23(30):5508-5518. doi: 10.3748/wjg.v23.i30.5508.
5
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
Br J Surg. 2010 Jun;97(6):853-61. doi: 10.1002/bjs.7000.
6
MicroRNA Expression Signatures During Malignant Progression From Barrett's Esophagus.
J Cell Biochem. 2016 Jun;117(6):1288-95. doi: 10.1002/jcb.25497. Epub 2016 Feb 16.
8
Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma.
Clin Cancer Res. 2010 Dec 1;16(23):5824-34. doi: 10.1158/1078-0432.CCR-10-1110. Epub 2010 Oct 14.
9
Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma.
Clin Cancer Res. 2005 Apr 1;11(7):2478-85. doi: 10.1158/1078-0432.CCR-04-1280.
10
HER2 expression in oesophageal carcinoma and Barrett's oesophagus associated adenocarcinoma: An Australian study.
Eur J Surg Oncol. 2016 Jan;42(1):140-8. doi: 10.1016/j.ejso.2015.08.159. Epub 2015 Sep 10.

引用本文的文献

1
ENPP4 overexpression is associated with no recovery from Barrett's esophagus.
Int J Clin Exp Pathol. 2020 Dec 1;13(12):2927-2936. eCollection 2020.
2
A narrative review of Barrett's esophagus in 2020, molecular and clinical update.
Ann Transl Med. 2020 Sep;8(17):1107. doi: 10.21037/atm-20-4406.
3
MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.
Oncol Rep. 2020 Nov;44(5):1971-1984. doi: 10.3892/or.2020.7751. Epub 2020 Sep 4.
4
Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma.
World J Gastroenterol. 2020 Jun 14;26(22):2889-2901. doi: 10.3748/wjg.v26.i22.2889.

本文引用的文献

2
The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
J Cell Physiol. 2018 Feb;233(2):774-786. doi: 10.1002/jcp.25813. Epub 2017 Mar 24.
4
The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
Eur J Cancer. 2017 Feb;72:1-11. doi: 10.1016/j.ejca.2016.11.004. Epub 2016 Dec 18.
5
Circulating miRNA profile in esophageal adenocarcinoma.
Am J Cancer Res. 2016 Nov 1;6(11):2713-2721. eCollection 2016.
6
Circulating MicroRNAs in Cancer.
Methods Mol Biol. 2017;1509:123-139. doi: 10.1007/978-1-4939-6524-3_12.
7
miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression.
Ann Surg. 2016 Nov;264(5):804-814. doi: 10.1097/SLA.0000000000001928.
10
MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.
Oncogene. 2017 Jan 12;36(2):231-241. doi: 10.1038/onc.2016.194. Epub 2016 Jun 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验